JOCKEY STAYER SEED TREATMENT FUNGICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jockey stayer seed treatment fungicide

bayer cropscience pty ltd - fluquinconazole - suspension concentrates for seed treatment (fs) - fluquinconazole azole active 167.0 g/l - fungicide - barley | canola | wheat | rapeseed - barley leaf scald | barley loose smut - ustilago nuda var ho | blackleg - suppression | covered smut - u. segetum var. segetum | covered smut (bunt) - tilletia spp. | flag smut on cereal | leaf rust - puccinia hordei | loose smut - ustilago tritici | powdery mildew on barley | septoria tritici blotch - supression | stripe rust | take-all of wheat | barley scald | bunt | common bunt | seedborne flag smut | soilborne flag smut | take-all of wheat - suppressio | ustilago nuda var hordei

Apo-Doxazosin New Zealand - English - Medsafe (Medicines Safety Authority)

apo-doxazosin

apotex nz ltd - doxazosin mesilate 1.22mg equivalent to 1 mg doxazosin;   - tablet - 1 mg - active: doxazosin mesilate 1.22mg equivalent to 1 mg doxazosin   excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - doxazosin is indicated for the treatment of hypertension and can be used as the initial agent to control pressure in the majority of patients. for patients who are not adequately controlled on a singel antihypertensive agent, doxazosin can be used in combination with another agent such as a thiazide diuretic, a beta-blocker, a calcium antagonist or an angiotensin-converting enzyme inhibitor.

Doxazosin New Zealand - English - Medsafe (Medicines Safety Authority)

doxazosin

clinect nz pty limited - doxazosin mesilate 2.44mg equivalent to 2 mg doxazosin;   - tablet - 2 mg - active: doxazosin mesilate 2.44mg equivalent to 2 mg doxazosin   excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - doxazosin is indicated for the treatment of hypertension and can be used as the initial agent to control pressure in the majority of patients. for patients who are not adequately controlled on a singel antihypertensive agent, doxazosin can be used in combination with another agent such as a thiazide diuretic, a beta-blocker, a calcium antagonist or an angiotensin-converting enzyme inhibitor.

Doxazosin New Zealand - English - Medsafe (Medicines Safety Authority)

doxazosin

clinect nz pty limited - doxazosin mesilate 4.87mg equivalent to 4 mg doxazosin;   - tablet - 4 mg - active: doxazosin mesilate 4.87mg equivalent to 4 mg doxazosin   excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - doxazosin is indicated for the treatment of hypertension and can be used as the initial agent to control pressure in the majority of patients. for patients who are not adequately controlled on a singel antihypertensive agent, doxazosin can be used in combination with another agent such as a thiazide diuretic, a beta-blocker, a calcium antagonist or an angiotensin-converting enzyme inhibitor.

APO-Prazosin New Zealand - English - Medsafe (Medicines Safety Authority)

apo-prazosin

apotex nz ltd - prazosin hydrochloride 1.1mg equivalent to 1 mg prazosin;  ; prazosin hydrochloride 1.1mg equivalent to 1 mg prazosin - tablet - 1 mg - active: prazosin hydrochloride 1.1mg equivalent to 1 mg prazosin   excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose polysorbate 80 quinoline yellow sunset yellow fcf active: prazosin hydrochloride 1.1mg equivalent to 1 mg prazosin excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose polysorbate 80 - hypertension: prazosin is effective in the management of primary hypertension, and also secondary hypertension from various causes. prazosin may be used as the sole agent, but it is generally more effective if used in combination with a diuretic. prazosin can be used successfully with other antihypertensive agents. prazosin may be used safely by hypertensive patients with impaired renal function. congestive cardiac failure: prazosin may be added to the therapeutic regime of patients who have become refactory to conventional therapy with cardiac glycosides and diuretics. raynaud's phenomenon and raynaud's disease benign prostatic hyperplasia: an adjunct in the symptomatic treatment of urinary obstruction caused by bph in patients waiting for prostatic surgery

APO-Prazosin New Zealand - English - Medsafe (Medicines Safety Authority)

apo-prazosin

apotex nz ltd - prazosin hydrochloride 2.2mg equivalent to 2 mg prazosin;   - tablet - 2 mg - active: prazosin hydrochloride 2.2mg equivalent to 2 mg prazosin   excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose polysorbate 80 - hypertension: prazosin is effective in the management of primary hypertension, and also secondary hypertension from various causes. prazosin may be used as the sole agent, but it is generally more effective if used in combination with a diuretic. prazosin can be used successfully with other antihypertensive agents. prazosin may be used safely by hypertensive patients with impaired renal function. congestive cardiac failure: prazosin may be added to the therapeutic regime of patients who have become refactory to conventional therapy with cardiac glycosides and diuretics. raynaud's phenomenon and raynaud's disease benign prostatic hyperplasia: an adjunct in the symptomatic treatment of urinary obstruction caused by bph in patients waiting for prostatic surgery